Drug Resistance Updates

ISSN: 1368-7646

Journal Home

Journal Guideline

Drug Resistance Updates Q1 Unclaimed

Churchill Livingstone United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine. It has an SJR impact factor of 4,01.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: Bi Monthly

Metrics

Drug Resistance Updates

4,01

SJR Impact factor

110

H Index

28

Total Docs (Last Year)

52

Total Docs (3 years)

6414

Total Refs

835

Total Cites (3 years)

52

Citable Docs (3 years)

17,23

Cites/Doc (2 years)

229,07

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Drug resistance in Cryptococcus neoformans

View more

Drug resistance in Giardia: clinical versus laboratory isolates

View more

Drug resistance in Leishmania: similarities and differences to other organisms

View more

Drug resistance in Pneumocystis carinii: an emerging problem

View more

Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

View more

Drugs and drug resistance in African trypanosomiasis

View more

Chemically modified tetracyclines as inhibitors of matrix metalloproteinases

View more

Definitive proof for a role of pfmdr 1 in quinoline resistance in Plasmodium falciparum

View more

39thInterscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) San Francisco, USA, 26-29 September 1999

View more

The 90th Annual Meeting of the American Association for Cancer Research (AACR) Philadelphia, USA, 10-14 April 1999

View more

Bacterial energetics and antimicrobial resistance

View more

Reversing drug resistance in bcl-2-expressing tumor cells by depleting glutathione

View more
SHOW MORE ARTICLES

Clinical cancer research 2000: new agents and therapies

View more

Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?

View more

Clinical cancer research 2001: new agents and therapies

View more

Subcellular targeting regulates the function of caspase-activated protein kinases in apoptosis

View more

Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?

View more

Clinical cancer research 2002: new agents and therapies

View more

Antifungal drug susceptibility testing and resistance in Aspergillus

View more

ATP-binding cassette transporters: from multidrug resistance to genetic disease, Gosau, Austria, 20-27 February 1999

View more

Erratum

View more

Phenotypic antibiotic tolerance of Staphylococcus aureus in implant-related infections: relationship with in vitro colonization of artificial surfaces

View more

New developments: Chloroquine-resistance in Plasmodium falciparum

View more

cDNA Technologies and their application to drug resistance research: power, potential and problems

View more

FAQS